Medify Solutions Ltd.

Medify Solutions Limited Announces Dividend

    Stafford, England, November 22 (ots/PRNewswire) - Medify Solutions Limited (OTC - MDFY), today announced that due  to the achievement of major performance milestones and the positive  circumstances created by the significant NHS developments, the company is  issuing a 1 for 4 (25%) share dividend. This is also in recognition by the  board that the activities announced to shareholders in June 2006 relating to  subsidiary floatation (and associated dividend) are currently suspended. The  subsidiary floatation status is unchanged from the most recently issued  Quarterly Report.

    The dividend is valid for all individuals holding shares in MDFY.pk as per the Medify Solutions Limited Shareholders of record at 5pm Eastern Standard Time on the 30th November 2006. The dividend will be paid in  MDFY.pk shares, (electronically if available for shareholders trading  accounts), viathe company transfer agent, Fidelity Transfer on the  15th December 2006.

    To clarify, for every 4 shares held by a shareholder at 5pm 30th November2006, a dividend of 1 share will be issued (by the Company) to that shareholder on 15th December 2006.

    It is the decision of the Board that the restricted stock issued to the management team during September 2006 will not be eligible for this dividend.

    Ian O'Reilly, CEO of Medify Solutions, Ltd., commented to shareholders: "given the major step changes we are seeing in the business and the impending announcements from the NHS, the board feels that this course of action is the correct response to our shareholders who continue to invest in the Company".

    This news release contains forward-looking statements that are subject  to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of such forward-looking statements. The words "estimate", "project", "intends", "expects",  "believes", and similar expressions are intended to identify forward-looking  statements. Such forward-looking statements are made based on management's  beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbour" provisions of the Private  Securities Litigation Reform Act of 1995. For a more complete description  of these and other risk factors that may affect the future performance of  Medify Solutions Limited, see "Risk Factors" in the Company's Annual Report  on Form 10-KSB and its other filings with the Securities and Exchange  Commission. Readers are cautioned not to place undue reliance on these  forward-looking statements, which speak only as of the date made and the  Company undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date  made or to reflect the occurrence of unanticipated events.

ots Originaltext: Medify Solutions Ltd.
Im Internet recherchierbar: http://www.presseportal.ch

Contact:
For further information: Press Office email:
press@medifysolutions.com; General email:
enquiries@medifysolutions.com; Fidelity Transfer: +1-801-484-7222;
More information at: www.medifysolutions.com



Weitere Meldungen: Medify Solutions Ltd.

Das könnte Sie auch interessieren: